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Review Article
SUMMARY 
Zika virus disease has resonated great concern globally. The World Health Organization declared it “a public health emergency of 
International concern” on 1st February, 2016. The recent outbreaks have become a major challenge due to a drift from its earlier 
known benign exanthematous spectrum to a causal link to microcephaly. Historically, the name Zika virus comes from the Zika 
Forest of Uganda. It was first identified in 1947 among Rhesus Macaque sub-population. Two genetically distinct isolates have 
been well characterized; the Asian and African strains. This virus is spread by bites of day-time-active Aedes mosquitoes; the 
Aedes aegypti and Aedes albopictus. Zika Virus appears to spread along a narrow equatorial belt of Africa to Asia through the 
Pacific Ocean to French Polynesia, New Caledonia (southwest Pacific Ocean), the Cook Islands (south Pacific), and Easter Island 
(a Chilean territory in Polynesia), and most recently to Mexico, Central America, the Caribbean, and South America, where today 
has assumed a pandemic proportion.
Up to eighty percent of infections are asymptomatic. Symptomatic infections are characterized by a self-limiting febrile illness 
and maculopapular rash, arthralgia, conjunctivitis, back pain and mild headaches. Maternal Zika viral load is thought to be a 
significant risk factor to fetal infection leading to invasion of either trophoblasts or placental cells or both through maternal 
decidua. Zika viral RNA proteins and associated extensive selective tissue injuries have been demonstrated in the brains and 
spinal cords of abortuses. Diagnosis of Zika virus is essentially based on viral RNA detection from clinical specimens. Currently, 
licensed preventive medicines or vaccines are unavailable. With the wide spate of recent outbreaks and consequent neurologic 
morbidity and mortality, there is need for deployment of point-of-care equipment for screening of pregnant women in our 
environment. This is an ambitious call for advocacy by all relevant health care providers.  
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INTRODUCTION
ika virus fever is anarthropod-borne Zviral infection caused by Zika 1v i r u s . I t  i s  a  F l a v i r u s  f r o m 
Flavivirdae family. Historically, its name 
comes from the Zika Forest of Uganda in East 
Africa where it was first identified in 1947, 
a m o n g  t h e  R h e s u s  M a c a q u e  s u b -
2population.  Two genetically distinct isolates 
have been characterized; the Asian and 
2-4African strains. 
The Zika virus is spread by bites from 
daytime-active Aedes mosquitoes; A. aegypti 
5and A. albopictus.  From the nineteen-fifties, 
this virus has been known to spread 
characteristically eastward and appears to 
do so within a narrow equatorial belt from 
Africa to Asia through the Pacific Ocean to 
F r e n c h  P o l y n e s i a ,  N e w  C a l e d o n i a 
(southwest Pacific Ocean), the Cook Islands 
(south Pacific), and Easter Island (a Chilean 
territory in Polynesia), and most recently to 
Mexico, Central America, the Caribbean, and 
South America, where today has assumed a 
6pandemic proportions. 
A population based-survey in 1947 in 
7Uganda found a prevalence of 6.1%.  
Another sero-prevalence survey among 
healthy population in sub-urban community 
in Indian found substantial antibodies to 
8Zika virus, suggesting a prior exposure.  The 
first reported human case of Zika virus 
9 infection in Nigeria was in 1954. In a 
population based study which included 60% 
pregnant women in north-central Nigeria, 
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(2018), Phillip et al found an anti-ZIKV 
positive rate of 6% for IgM and 4% for IgG. 
Pregnant women showed antiZIKV positive 
rates of 4% for IgM and 3% for IgG. A 
significant association with male sex was 
found for anti-ZIKV IgG ELISA positivity 
(prevalence ratio 3.49; 95% CI: 1.48–8.25; 
p = . 0 0 4 ) .  I n  t h e  s a m e  s t u d y ,  Z I K V 
neutralizing antibodies were detected in 
1 7 / 1 8  ( 9 4 % )  a n t i - Z I K V  N S 1 
positive/borderline samples and in one 
sample without detectable ZIKV NS1 
antibodies. Partial ZIKV E gene sequence was 
retrieved in one sample without ZIKV 
antibodies, which clustered within the West 
10African ZIKV lineage.
The virus may be transmitted vertically from 
an infected pregnant mother to her unborn 
baby. This intra-uterine infection has recently 
been causally associated with microcephaly. 
Infection in adult sub-population may also 
resu l t  in  Gui l la in -Barre  syndrome. 
11Currently, prevention medicines and 
vaccines against Zika virus fever does not 
12exist.
With increased global travels for economic, 
medical and social tourisms, no country of 
the world is immune to this infectious virus. 
While there are plethora of literature and 
ongoing research efforts on the Zika virus 
infection in some parts of the world, same 
cannot be said in our setting. The aim of this 
a r t i c l e  t h e r e f o r e ,  i s  t o  p r o v i d e  a n 
epidemiological review of Zika Virus Disease 
and to highlight relevant lessons that could 
be learnt from previous Zika virus outbreaks 
in regard to epidemic preparedness.
Documented outbreaks
The discovery of Zika virus was rather an 
incidental finding. In April, 1947, a team of 
scientists of the Yellow Fever Research 
I n s t i t u t e  fi r s t  i s o l a t e d  a  fi l t e r a b l e 
transmissible infectious particle from serum 
of a febrile rhesus macaque monkey which 
had been placed in a cage in the Zika Forest of 
13Uganda near Lake Victoria.  This team of 
researchers at the time was working on 
13Yellow Fever Virus project. A second viral 
isolation was subsequently made in January, 
1948 from Aedes africanus among the same 
14, 15sub-populations of febrile monkeys. 
The first evidence suggestive of human 
Zika virus infection
Historically, Zika virus has been known to 
infect human subjects from previous 
serological surveys in Uganda and Nigeria: 
Fifty of 84 cohort screened for Zika virus were 
seropositive and all of who were over 40 
14years of age.  A similar survey amongst 
Indian natives demonstrated strong 
immunogenicity. Both studies cited above 
suggests widespread Zika virus infection in 
16human population.
In 1952, a team of scientists was investigating 
a suspected Yellow Fever outbreak in a 10-
year old Nigerian female who had fever, 
headaches, joint pain but no jaundice and had 
recovered spontaneously from her illness 
within few days. Her blood was injected into 
the brain of a laboratory mice. The virus 
isolates from the mouse brain was then tested 
for neutralizing specific antibodies to Zika 
virus using rhesus monkey sera. Curiously, 
no virus was isolated from the blood of two 
infected adults with fever, jaundice, cough, 
diffuse joint pains in one of the adults and 
fever, headaches, and arthralgia. Zika virus 
infection was then isolated in human for the 
first  t ime.  In  1954,  the  finding was 
17published.
Zika virus spread in Equatorial Africa and 
Asia, 1952 to 1983
Between 1951 and 1983, clinical and 
laboratory evidence of human Zika virus 
were subsequently reported from other 
African countries like the Central African 
Republic, Egypt, Gabon, Sierra Leon, 
Tanzania and Uganda. Similar reports were 
documented in other parts of Asia such as 
India, Malaysia, the Pakistan, Philippines, 
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18,19Vietnam and Thailand.  As at 2007, 
fourteen countries had confirmed human 
cases of Zika fever from continents of Africa 
20and South-East Asia. 
ZVD Outbreak in Micronesia, 2007
The first and major reported outbreak of zika 
fever outside the continents of Africa and 
Asia was in April, 2007 on the Yap Island 
Federation, Micronesia. The commonest 
clinical manifestations were fever, skin rash, 
2 1arthralgia and conjunctivitis. These 
symptomatology was previously considered 
to be dengue, Chikungunya or the Ross River 
disease. However, during the acute phase of 
the disease, 108 Zika RNA seropositiveby 
PCR or serology and 72 additional suspect 
cases. No morbidity or mortality from ZVD 
22was recorded. 
The predominant mosquito vector spp. 
identified was Aedes hensilli. While the mode 
of introduction of the Zika fever had 
remained elusive, it was thought to have 
happened through infected mosquitoes or a 
human infected with related strains from the 
23Southeast Asia.
Oceania ZVD outbreak of 2013 to 2014
Between 2013 and 2014, pockets of Zika fever 
outbreaks were reported. Among those were 
in the French Polynesia, Easter Island, New 
Caledonia and the Cook Islands. The virus 
source of this outbreak was not immediately 
clear. It was however, thought to be an 
independent introduction from those of the 
Southeast Asia which was linked to the Yap 
24Island outbreak described above. 
The Americas: Zika virus Outbreak from 
2015 to date
In February 2014, Zika virus outbreak was 
reported throughout South and Central 
America, and by November of 2015, it had 
25 reached Mexico. Ten confirmed cases of Zika 
travel-related infections were reported in 
Dallas and Texas, United States of America 
and Europe without identifiable mosquito 
26 vectors. Sexual transmission of Zika virus 
was reported almost for the first time in Texas 
25,27in February 2016. .
Brazilian health authorities reported its first 
16 cases of Zika fever in 14 states of the 
28 country as at May, 2015. By December 12, 
2015, the Brazilian Ministry of Health 
reported about 2,400 suspected cases of 
microcephaly in the country, of which 29 
29-31cases resulted in mortality.  In the State of 
Pernambuco alone, cases of microcephaly 
had exponentially rose from 150 to 200 per 
32 year the preceding 5 years. A mathematical 
model estimated the risk of microcephalyto 
1% of all infants born to Zika virus 
seropositive mothers in the first trimester of 
33pregnancy. 
On January 2016 WHO issued a public health 
warning of possible Zika virus spread to 
contiguous countries of the Americas 
because of the bionomics of the Aedes 
34mosquito vector.  By February, 2016, it 
declared Zika virus a Public Health 
Emergency of International Concern because 
of compelling evidence of pregnancy loss, 
35birth defects and other neurological deficits.  
In April 2016, there was an expert consensus 
on Zika related microcephaly and Guillain-
36, 37Barre syndrome in human adult. 
Aetiology of ZVD
Zika fever is caused by Zika virus. It is an 
envelope, icosahedral, non-segmented 
single- stranded, positive-sense RNA virus, 
aFlavirus from the Flaviviridae family. Viral 
particles are 40nm in diameter with an outer 
38,39,40envelope and a dense inner core Thus, it is 
related to dengue, yellow fever, Japanese 
encephalitis and West Nile virus.
Transmission
Zika virus disease is predominantly spread 
through the bite of infected female Aedes 
41 mosquito. An infected male can transmit the 
virus to his sex partner. Sexual transmission 
has been reported in 6 countries: Argentina, 
Chile, France, Italy, New Zealand and the 
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11 United States of America in 2015 Zika virus 
transmission via blood and blood products 
42transfusions have also been documented.  In 
April, 2016, 2 cases were reported both from 
43Brazil. Transplacental spread from an 
infected pregnant mother to her unborn baby 
or at delivery (birth canal) have been 
11, 44recognized 
The Aedes mosquito vector is very active 
during day time. It breeds around stagnant 
water, abandon automobile parts, flower 
vases, uncovered buckets and wet shower 
flows. Only the female bites for blood, 
r e q u i r e d  t o  m a t u r e  h e r  e g g s . 
Characteristically, she bites 4 to 5 times a day 
in the afternoon and early in the evenings. 
There are two types: the Aedes egypti and 
45Aedes albopictus.
Pathogenesis 
Zika virus replicates in the epithelial lining of 
the mid-gut and the salivary cells of mosquito 
vector. After a variable period of about 5 
days, it appears in the mosquito saliva which 
subsequently becomes infectious. During 
blood meal, the vector inoculates its human 
host skin. The virus may then infect the 
epidermal keratinocytes, the fibroblast and 
the Langerhans cells. It is thought that, the 
Zika virus spreads to the lymphatic and 
3,8,46haematogenously.  In stark contrast to 
other Flaviruses, its antigen has been 
46demonstrated in host cell nucleic.  
Clinical features
Up to eighty per cent of infections are 
48asymptomatic. Symptomatic (viraemic 
stages)of infections are characterized by a 
self-limiting febrile illness of 4–7 days 
duration associated by maculopapular rash, 
arthralgia, conjunctivitis, back pain and mild 
headaches.Within 2 days, skin rash begin to 
fade spontaneously and within 3 days, fever 
49starts to resolve and only few rash persists.
Maternal Zika viral load is thought to be a 
significant risk factor to fetal infection. The 
mechanism for intra-uterine infection is not 
completely clear. It is thought that, maternal 
Zika viraemia is critical to invasion of either 
trophoblasts or placental cells or both 
through maternal decidua. Zika virion then 
binds to maternal intervillous spaces by a 
process of transcytosis to yet unidentified 
receptors. It said to now replicates more 
efficiently in FcyR in myeloid cells. Zika viral 
RNA proteins and associated extensive 
se lec t ive  t i s sue  in jur ies  have  been 
demonstrated in the brains and spinal cords 
50of abortuses.
Gullain-Barre syndrome is thought to be due 
to immunopathology resulting from 
antigenic mimicry of a host protein. Zika 
virus appears to have selective tropism to 
neurons/glial cells causing demyelination of 
affected neurons. Frequently reported 
clinical manifestations include: muscle 
weakness, tingling sensations on the arms 
and legs and parasthesias. Recently, a 
positive association has been observed with 
45prior or concurrent Dengue virus infections.
Some yet  unanswered pathogenet ic 
questions about Zika virus disease; are there 
sanctuary sites for Zika virus in human host? 
What is the nature of pathologic lesions of the 
virus and why only certain individual human 
hosts manifest the disease? Detailed 
longitudinal studies are needed to answer 
51such questions. 
Ultrasonographic findings at 18 to 19 week's 
gestation suggestive of Zika virus infection 
includecerebral hemispheres were markedly 
a s y m m e t r i c  ( s e v e r e  u n i l a t e r a l 
ventriculomegaly) - almost complete 
disappearance or failure to develop the 
50 thalami - thin pons and brainstem Mother.
By the 29 weeks intra-uterine life, observed 
c h a n g e s  b e c o m e  e v i d e n t  s u c h  a s 
microcephaly, brain atrophy with coarse 
calcifications involving the white matter of 
the frontal lobes, the caudate nucleus, 
lentostriatal vessels and the cerebellum. 
Other notable sonographic anomalies are 
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dysgenesis of the vermis and corpus 
callosumand enlargement of the cisterna 
51magna. 
Laboratory Diagnosis
Diagnosis of Zika virus is essentially based 
on viral RNA detection from clinical 
specimens. Direct virus detection is only 
during the first 3 to 5 days after onset of 
1, 52, 53symptoms Specific assays targeting the 
Asian and African Zika virus isolates of the 
1 , 5 2envelope gene or NS5 region Pan-
flavivirus assays and sequencing analysis can 
be used as a surrogate for possible Zika virus 
53,54infection 
Saliva and urine specimens for viral genome 
detection by RT-PCR might be diagnostic. 
ZIKV-specific IgM/IgG antibodies can be 
detected by ELISA and immunofluorescence 
assays in serum specimens, usually from day 
five or six of symptomatic illness. 
False positive test results may be with dengue 
and other Flavivirus infections. A positive 
result for dengue IgM antibodies without 
detection of dengue IgG in paired sera among 
travellers returning from areas affected by 
ZIKV should prompt a possible investigation 
for another flavivirus aetiology. Positive 
results should be confirmed by neutralization 
test.
Treatment
At the moment, no preventive medicines or 
vaccines are available. However, Zika virus 
disease symptoms may be controlled with 
bed rest, intravenous fluids and 
55acetaminophen 
Vaccine development
As at January 2016, the NIH Vaccine Research 
Center started some work toward s 
56development of effective vaccine for Zika.  In 
February, 2016, Bharat Biotech International 
announced it was developing 2 candidate 
vaccines; recombinant and inactivated Zika 
vaccines, both of which are at preclinical 
5 7s tages  o f  deve lopment .   e ighteen 
international companies as at March, 2016 
have been working very hard to produce 
vaccines against Zika virus, but known had 
58reached clinical trials 
CONCLUSION
With wide distribution of competent Aedes 
aegypti and Aedes albopictus mosquito vectors 
in the Americas, some European countries, 
sub-saharan Africa including Nigeria, the 
unfortunate absence of available vaccines 
globally, ZIKV Disease spread is likely to 
continue for some time. These possibilities 
are significantly made even easier by 
increased global travels for both economic 
and tourism purposes. The causal link of 
ZIKV infection to abortion, microcephaly and 
other Central Nervous System anomalies has 
further made it even urgent for coordinated 
effort by health authorizes of other seeming 
Zika-free countries to set up surveillance and 
containment strategies in countries where the 
Aedes  mosquito  vectors  are  equal ly 
abundant. In addition, deployment of point-
of-care equipment for screening of pregnant 
women in antenatal clinics may be helpful in 
our environment. This, is an ambitious call 
for advocacy by all relevant health care 
providers.  
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